Stem cells and cancer immunotherapy: Arrowhead’s 2nd annual cancer immunotherapy conference

DSpace/Manakin Repository

Stem cells and cancer immunotherapy: Arrowhead’s 2nd annual cancer immunotherapy conference

Citable link to this page

 

 
Title: Stem cells and cancer immunotherapy: Arrowhead’s 2nd annual cancer immunotherapy conference
Author: Bot, Adrian; Chiriva-Internati, Maurizio; Cornforth, Andrew; Czerniecki, Brian J; Ferrone, Soldano; Geles, Kenneth; Greenberg, Philip D; Hurt, Elaine; Koya, Richard C; Manjili, Masoud H; Matsui, William; Morgan, Richard A; Palena, Claudia M; Powell Jr , Daniel J; Restifo, Nicholas P; Spencer, David M; Vizcardo, Raul; Wong, Albert J; Yang, Lili; Yu, John

Note: Order does not necessarily reflect citation order of authors.

Citation: Bot, A., M. Chiriva-Internati, A. Cornforth, B. J. Czerniecki, S. Ferrone, K. Geles, P. D. Greenberg, et al. 2014. “Stem cells and cancer immunotherapy: Arrowhead’s 2nd annual cancer immunotherapy conference.” Journal for Immunotherapy of Cancer 2 (1): 6. doi:10.1186/2051-1426-2-6. http://dx.doi.org/10.1186/2051-1426-2-6.
Full Text & Related Files:
Abstract: Investigators from academia and industry gathered on April 4 and 5, 2013, in Washington DC at the Arrowhead’s 2nd Annual Cancer Immunotherapy Conference. Two complementary concepts were discussed: cancer “stem cells” as targets and therapeutic platforms based on stem cells.
Published Version: doi:10.1186/2051-1426-2-6
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019892/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:12406942
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters